Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.4105 USD | +0.12% | +2.73% | -6.68% |
May. 16 | Transcript : AIM ImmunoTech Inc., Q1 2024 Earnings Call, May 16, 2024 | |
Apr. 29 | AIM ImmunoTech Says Safety Evaluation of First Dose Level of Pancreatic Cancer Study Completed | MT |
Chart: Technical Analysis
Technical analysis trends
Short Term | Mid-Term | Long Term | |
---|---|---|---|
Trend | Bearish | Neutral | Neutral |
Resistance | 0.4888 | 0.6141 | 0.7000 |
Spread/Res. | -16.02% | -33.15% | -41.36% |
Spread/Supp. | +6.79% | +24.39% | +24.39% |
Support | 0.3844 | 0.3300 | 0.3300 |
Technical Rankings Surperformance
Short Term Timing | |
---|---|
Middle Term Timing | |
Long Term Timing | |
RSI | |
Bollinger Spread | |
Unusual Volumes |
- Stock Market
- Equities
- AIM Stock
- Charts AIM ImmunoTech Inc.